Literature DB >> 19785988

RACK1 associates with CLEC-2 and promotes its ubiquitin-proteasome degradation.

Yuanyuan Ruan1, Liang Guo, Ying Qiao, Yi Hong, Lei Zhou, Linlin Sun, Lijing Wang, Haiyan Zhu, Lan Wang, Xiaojing Yun, Jianhui Xie, Jianxin Gu.   

Abstract

CLEC-2 is a C-type lectin-like receptor and plays an important role in platelet activation. Snake venom toxin rhodocytin and the endogenous sialoglycoprotein podoplanin are identified as ligands for CLEC-2 and function as stimulators in platelet activation. We also previously indentified two splice variants of murine CLEC-2 as well as a soluble fragment cleaved from the full-length form. However, little is known about the interacting partners with the cytoplasmic region of CLEC-2. In this study, we reported that RACK1, the receptor for activated C-kinase 1, associated with the cytoplasmic tail of CLEC-2. Moreover, overexpression of RACK1 decreased the stability of CLEC-2 through promoting its ubiquitin-proteasome degradation, without impairing surface expression and downstream signaling of CLEC-2. Taken together, these results suggest RACK1 as a novel modulator of CLEC-2 expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19785988     DOI: 10.1016/j.bbrc.2009.09.087

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  The production of soluble C-type lectin-like receptor 2 is a regulated process.

Authors:  Min Fei; Lei Zhou; Jianhui Xie; Yuanyuan Ruan; Jiejie Xu; Songbin He; Hongjie Shen; Yumin Hu; Shifang Ren; Changgeng Ruan
Journal:  Glycoconj J       Date:  2012-06-27       Impact factor: 2.916

2.  RAB40C regulates RACK1 stability via the ubiquitin-proteasome system.

Authors:  Jon P Day; Ellanor Whiteley; Michael Freeley; Aideen Long; Beatrice Malacrida; Patrick Kiely; George S Baillie
Journal:  Future Sci OA       Date:  2018-07-02

3.  RACK1 Promotes Self-Renewal and Chemoresistance of Cancer Stem Cells in Human Hepatocellular Carcinoma through Stabilizing Nanog.

Authors:  Junxia Cao; Min Zhao; Jian Liu; Xueying Zhang; Yujun Pei; Jingyang Wang; Xiao Yang; Beifen Shen; Jiyan Zhang
Journal:  Theranostics       Date:  2019-01-24       Impact factor: 11.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.